Related Experiment Video
Updated: May 1, 2026

09:44
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
7.4K
Patterns of retreatment by radiotherapy
M B Barton1, S Allen1, G P Delaney1
1Collaboration for Cancer Outcomes and Research, Ingham Institute, University of New South Wales, Liverpool, Australia.
Summary
This study analyzed radiotherapy retreatment patterns across three international centers. Findings show similar retreatment rates, suggesting consistent clinical practice for cancer therapy.
Area of Science:
- Oncology
- Radiation Oncology
- Health Services Research
Background:
- Radiotherapy retreatment, defined as subsequent courses of radiation therapy for the same cancer diagnosis, is a crucial aspect of cancer care.
- Understanding retreatment patterns is essential for optimizing service planning and establishing benchmarks in radiation oncology.
Purpose of the Study:
- To describe and analyze patterns of radiotherapy retreatment across different cancer types.
- To compare retreatment rates and timing between three international cancer therapy centers.
Main Methods:
- A retrospective analysis of institutional databases from 1991-2009 was conducted.
- Data included patients receiving their first megavoltage radiotherapy for any cancer type at centers in Australia and the Netherlands.
- Retreatment was defined as any radiotherapy episode after an initial course for the same diagnosis.
Main Results:
- A total of 62,270 patients received 77,762 radiotherapy episodes, with a 16% retreatment rate (two or more episodes).
- Overall retreatment rates were consistent across the three centers (0.24-0.26).
- Median time between treatments varied by cancer type, longest for breast cancer (11.3 months) and shortest for lung cancer (4.1 months).
Conclusions:
- The study found very similar retreatment rates among the three facilities.
- This similarity suggests a consensus regarding the indications for radiotherapy retreatment in clinical practice.
Related Concept Videos
Treatment Resistent Cancers
1.1K
1.1K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K

